The state of cancer care in Russia: epidemiology and survival of patients with the most common and life-threatening solid malignancies. Part 2 (a population-based study at the federal district level)

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The first part of our research focused on studying the prevalence of major solid and life-threatening malignant neoplasms. In the second part, we examine the patterns of effectiveness of anti-cancer measures in Russia, calculating the observed and relative one-year survival rates. This became possible due to the formation of the population cancer registry at the federal district level. Notably, the standardized incidence and mortality rates for malignant neoplasms are similar across Russia, including the Northwestern Federal District, and therefore our materials reflect the overall state of cancer care on in the country, excluding national districts. The population covered by the population-based cancer registry of the Northwestern Federal District of Russia is approximately 14 million people (which is more than the population of Belarus, Latvia and Estonia combined), with over 1.5 million records in the database. Using this registry, we calculated the rates of observed and relative one-year survival for the most common and life-threatening solid malignant neoplasms. We also used data from the International Agency for Cancer Research and the directory of the N. N. Petrov Research Institute of Oncology (St. Petersburg). Data was processed using licensed programs MS Excel 2013–2016 and STATISTICA 6.1. The survival rates were calculated using the modified Eurocare program, along with mathematical, bibliographic, and statistical methods.

For the first time in Russia, the age-related patterns of one-year survival in patients with the most common and life-threatening solid malignant neoplasms. The first population-based study of one-year survival rate dynamics in patients with major solid and life-threatening localizations of malignant neoplasms conducted in Russia at the federal district level revealed an increase in these rates, except for the results for elderly and long-lived groups.

作者简介

Vakhtang Merabishvili

N.N. Petrov National Medical Research Centre of Oncology, St. Petersburg

编辑信件的主要联系方式.
Email: MVM@niioncologii.ru
ORCID iD: 0000-0002-1521-455X
SPIN 代码: 5705-6327

H.S., MD, Dr. Sci. (Medicine), Professor

俄罗斯联邦, 68 Leningradskaya street, Pesochny, Saint Petersburg 197758

Pavel Rumyantsev

My Medical Center LLC

Email: pavelrum@gmail.com
ORCID iD: 0000-0002-7721-634X
SPIN 代码: 7085-7976

MD

俄罗斯联邦, St. Petersburg 191186

Julia Yurkova

N.N. Petrov National Medical Research Centre of Oncology, St. Petersburg

Email: ula2@yandex.ru
ORCID iD: 0000-0002-5448-8115
SPIN 代码: 4697-6433

MD

俄罗斯联邦, 68 Leningradskaya street, Pesochny, Saint Petersburg 197758

Anna Artemyeva

N.N. Petrov National Medical Research Centre of Oncology, St. Petersburg

Email: oinochoya@gmail.com
ORCID iD: 0000-0002-2948-397X
SPIN 代码: 5760-5463

MD, Cand. Sci. (Medicine)

俄罗斯联邦, 68 Leningradskaya street, Pesochny, Saint Petersburg 197758

Alexey Belyaev

N.N. Petrov National Medical Research Centre of Oncology, St. Petersburg

Email: bam281060@yandex.ru
ORCID iD: 0000-0001-5580-4821
SPIN 代码: 9445-9473

MD, Dr. Sci. (Medicine), Professor, corresponding member of the Russian Academy of Sciences

俄罗斯联邦, 68 Leningradskaya street, Pesochny, Saint Petersburg 197758

参考

  1. Berrino F, Sant M, Verdecchia V, et al, editors. Survival of cancer patients in Europe: the EUROCARE Study (IARC Scientific Publications No. 132). Lyon: International Agency for Research on Cancer; 1995.
  2. Berrino F, Capocaccia R, Coleman MP, et al, editors. Survival of cancer patients in Europe: the EUROCARE-2 study (IARC Scientific Publications No. 151). Lyon: International Agency for Research on Cancer; 1999.
  3. Sant M, Aareleid T, Berrino F, et al. EUROCARE-3: the survival of cancer patients diagnosed 1990–94 — results and commentary. Ann Oncol. 2003;14(Suppl. 5):V61–V118. doi: 10.1093/annonc/mdg754
  4. Capocaccia R, Gavin A, Hakulinen T, Lutz JM, Sant M. Survival of cancer patients in Europe, 1995–2002. The EUROCARE 4 study. Eur J Cancer. 2009;45(6).
  5. De Angelis R, Sant M, Coleman M, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 — a population-based study. Lancet Oncol. 2014;15(1):23–34. doi: 10.1016/S1470-2045(13)70546-1
  6. Shcherbuk YuA, editor. Merabishvili VM. Survival of cancer patients. Issue two. Part I. Saint Petersburg: Izdatel’sko-poligraficheskaya kompaniya “KOSTA”; 2011. (In Russ). EDN: VITKUL
  7. Shcherbuk YuA, editor. Merabishvili VM. Survival of cancer patients. Issue two. Part II. Saint Petersburg: Izdatel’sko-poligraficheskaya kompaniya “KOSTA”; 2011. (In Russ.) EDN: QLZWFF
  8. Belyaev AM, Shcherbakov AM, editors. Merabishvili VM. Malignant neoplasms in the North-West Federal District of Russia (morbidity, mortality, reliability of accounting, survival rate of patients). Express-information. Issue five. Saint Petersburg; 2020. (In Russ.)
  9. Belyaev AM, editor. Merabishvili VM. Malignant neoplasms in the North-West Federal District of Russia (morbidity, mortality, reliability of accounting, survival rate of patients). Express-information. Issue six. Manual for doctors. Saint Petersburg; 2023. (In Russ).
  10. Merabishvili VM, Belyaev AM. The state of cancer care in Russia: one-year survival rate of patients with malignant neoplasms and first-year mortality rate for cancer of any site. (Population study at the federal district level). Voprosy Onkologii. 2023;69(1):55–66. doi: 10.37469/0507-3758-2023-69-1-55-66
  11. Merabishvili VM, Belyaev AM. The state of oncology care in Russia: dynamics of five-year survival of patients with malignant neoplasms and its ranked distribution across all tumor sites. Population study at the level of the Northwestern Federal District of Russia. Voprosy Onkologii. 2023;69(2):227–237. doi: 10.37469/0507-3758-2023-69-2-227-237
  12. Hakulinen T. On long-term relative survival rates. J Chronic Dis. 1977;30(7):431–443. doi: 10.1016/0021-9681(77)90036-4
  13. Parkin DM, Hakulinen T. Cancer registration: principles and methods. Analysis of survival. IARC Sci Publ. 1991;(95):159–176.
  14. Aareleĭd TP. Calculation of survival rates of patients with breast cancer in the Estonian SSR, 1968-1981. Voprosy onkologii. 1986;32(12):8–12.
  15. Black RJ, Sharp L, Kendrick SW. Trends in cancer survival in Scotland 1968-90. Edinburg; 1993.
  16. Ederer F. A simple method for determining standard errors of survival rates, with tables. J Chronic Dis. 1960;11:632–645. doi: 10.1016/0021-9681(60)90062-x
  17. Berezkin DP. Survival studies and individual prognosis in malignant tumors. In: General Oncology: A Guide for Physicians. Napalkov NP, editor. Leningrad: Meditsina; 1989. P:608–632. (In Russ.)
  18. Berezkin DP. Methods of studying the survival rate of cancer patients. Methodological recommendations. Leningrad, 1982. (In Russ.)
  19. Ivanov OA, Sukharev AE, Starinskii VV, Egorov SN. Method of processing the database of cancer patients (survival rates). Methodological Recommendations No 97/85. Moscow; 1997. (In Russ.)
  20. Napalkov NP, Berezkin DP. Principles and methods of studying survival of cancer patients. Voprosy Onkologii. 1982;(8):10–13. (In Russ.)
  21. Petrova GV, Gretsova OP, Kharchenko NV. Methods of calculating survival rates. In: Malignant neoplasms in Russia in 2003 (morbidity and mortality). Chissov VI, Starinskii VV, Petrova GV, editors. Moscow; 2005. P:246–254. (In Russ).
  22. Filatov VN. Principles and methods of studying survival rate as a criterion of effectiveness of treatment of patients with malignant neoplasms [dissertation]. Leningrad; 1991. (In Russ).
  23. Yakovlev AYu, Kadyrova IO, Tsibul’skii VM, Rzhonsnitskaya LP. Automated nonparametric analysis of cancer patient survival data. Leningrad; 1985. (In Russ).
  24. Merabishvili VM, Shakhzadova AO, Kulyova SA, Perelygin VV. The state of cancer care in Russia: age and cancer. Features of the localization structure of the quality of accounting and survival of patients with malignant tumors among the child population, adolescents and young adults in Russia (clinical and population study). Part 1. Pharmacy Formulas. 2023;5(1):20–32. doi: 10.17816/phf568263
  25. Merabishvili VM, Shakhzadova AO, Kulyova SA, Perelygin VV. State of oncological care in Russia: age and cancer. Features of the localization structure, quality of recording, and survival of young adults with malignant neoplasms (clinical-population study). Part 2. Pharmacy Formulas. 2023;5(2):24–37. doi: 10.17816/phf595705
  26. Merabishvili VM, Shakhzadova AO, Perelygin VV. State of cancer care in Russia: Age and cancer. Features of localization structure, quality of recording, and survival of middle-aged patients with CNS tumors (a clinical-population study). Part 3. Pharmacy Formulas. 2023;5(2):38–51. doi: 10.17816/phf605680
  27. Merabishvili VM, Shakhzadova AO, Perelygin VV. The state of cancer care in Russia: age and cancer. Features of localization structure, quality of accounting and survival of elderly patients with ZNO (population study). Part 4. Pharmacy Formulas. 2023;5(3):16–29. doi: 10.17816/phf607353
  28. Merabishvili VM. Oncologic statistics (traditional methods, new information technologies): a guide for physicians. Part I. Saint Petersburg: Izdatel’sko-poligraficheskaya kompaniya “KOSTA”; 2011. (In Russ.)
  29. Merabishvili VM. Oncologic statistics (traditional methods, new information technologies): a guide for physicians. Part II. Saint Petersburg: Izdatel’sko-poligraficheskaya kompaniya “KOSTA”; 2011. (In Russ.)

补充文件

附件文件
动作
1. JATS XML
下载
2. Fig. 1. Dynamic of age-related one-year survival of patients with malignant tumors in the Northwestern Federal District of the Russian Federation, C00-96 (mail).

下载 (131KB)
索引源数据
3. Fig. 2. Dynamic of age-related one-year survival of patients with malignant tumors in the Northwestern Federal District of the Russian Federation, C00-96 (female).

下载 (131KB)
索引源数据
4. Fig. 3. Age-specific one-year survival of mail with lung cancer (C33, 34) in the Northwestern Federal Districts of the Russian Federation.

下载 (110KB)
索引源数据
5. Fig. 4. Age-specific one-year survival of female with lung cancer (C33, 34) in the Northwestern Federal Districts of the Russian Federation.

下载 (111KB)
索引源数据
6. Fig. 5. Age-specific one-year survival of mail with stomach cancer (C16) in the Northwestern Federal Districts of the Russian Federation.

下载 (104KB)
索引源数据
7. Fig. 6. Age-specific one-year survival of female with stomach cancer (C16) in the Northwestern Federal Districts of the Russian Federation.

下载 (116KB)
索引源数据
8. Fig. 7. Age-specific one-year survival of mail with colon cancer (C18) in the Northwestern Federal Districts of the Russian Federation.

下载 (110KB)
索引源数据
9. Fig. 8. Age-specific one-year survival of female with colon cancer (C18) in the Northwestern Federal Districts of the Russian Federation.

下载 (116KB)
索引源数据
10. Fig. 9. Age-specific one-year survival of female with breast cancer (C50) in the Northwestern Federal Districts of the Russian Federation.

下载 (119KB)
索引源数据
11. Fig. 10. Age-specific one-year survival of female with corpus uteri cancer (C54) in the Northwestern Federal Districts of the Russian Federation.

下载 (127KB)
索引源数据
12. Fig. 11. Age-specific one-year survival of male with liver cancer (C22) in the Northwestern Federal Districts of the Russian Federation.

下载 (110KB)
索引源数据
13. Fig. 12. Age-specific one-year survival of female with liver cancer (C22) in the Northwestern Federal Districts of the Russian Federation.

下载 (113KB)
索引源数据
14. Fig. 13. Age-specific one-year survival of male with pancreas cancer (C25) in the Northwestern Federal Districts of the Russian Federation.

下载 (105KB)
索引源数据
15. Fig. 14. Age-specific one-year survival of female with pancreas cancer (C25) in the Northwestern Federal Districts of the Russian Federation.

下载 (104KB)
索引源数据

版权所有 © Eco-Vector, 2024


 


Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».